Basilea announces approval of antibiotic Zevtera® in China to treat community-acquired pneumonia and hospital-acquired pneumonia

    NEXT STORY
    Two new members of ALK’s Board of Directors
    PREV STORY
    1Life Healthcare (One Medical) Executives to Participate in Upcoming Investor Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Foamix Reports Second Quarter 2016 Financial Results and Provides Business Update

    REHOVOT, Israel, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix Pharmaceuticals” or ...

    author_avatar
    NASDAQ Market News

    Affimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA(R) (pembrolizumab) for Patients with Hodgkin Lymphoma

    HEIDELBERG, Germany, Jan. 25, 2016 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq:AFMD), a clinical stage ...

    author_avatar
    NASDAQ Market News

    Theratechnologies Issues Preliminary Revenue Estimates for Fiscal Year 2019 and Revenue Guidance for Fiscal Year 2020

    author_avatar
    NASDAQ Market News